AI-Powered Clinically Validated Adaptive Therapy

Adaptive Neurorehabilitation Powered by Real‑Time Intelligence

Personalized therapy for Parkinson’s disease and neurological disorders using AI-driven adaptive cycling.

Explore Technology View Clinical Evidence
AR is not supported on this device

Drag to explore the device in 3D

The platform

Intelligent rehabilitation, personalized for every patient

Adaptix Neuro is an AI-enabled rehabilitation platform that combines a motorized stationary bike with real-time adaptive control and physiological feedback.

Unlike traditional rehabilitation systems, Adaptix Neuro continuously monitors user performance and dynamically adjusts therapy parameters — delivering personalized, optimized exercise in every session.

  • Real-time adaptive control
  • Personalized therapy based on patient response
  • Continuous performance monitoring
  • Designed for clinical and home environments
Monitorperformance & responseAdapttherapy parametersDeliverpersonalized session CLOSED LOOP every session, in real time
Performance is sampled during the ride, and the therapy responds to it — not the other way round.

The problem

A smarter approach to neurorehabilitation

Parkinson’s disease affects over 10 million people worldwide, yet current rehabilitation approaches remain largely static and non-personalized .

The Challenge

  • Therapy is often not tailored to individual response
  • Outcomes vary significantly between patients
  • Limited real-time feedback and optimization

Our Solution

Adaptix Neuro introduces a closed-loop, data-driven approach that adapts therapy in real time, helping maximize patient engagement and therapeutic outcomes.

  • Closed-loop
  • Data-driven
  • Real-time

The evidence

Backed by research, designed for outcomes

Adaptix Neuro is built on more than 15 years of peer-reviewed research in dynamic cycling therapy and adaptive rehabilitation.

Our approach combines clinical evidence with engineering innovation to deliver measurable, meaningful improvements in patient outcomes.

15+

years of peer-reviewed research in dynamic cycling therapy and adaptive rehabilitation

Motor function improvement

Early study results

0% 10% 20% +13% +22% Baseline 3 sessions 12 sessions

Early studies have shown up to 13% improvement in motor function after 3 sessions, and up to 22% after 12 sessions.

The team

Led by experts in engineering, clinical research, and commercialization

  • Portrait of Haston Abdar CEO

    Haston Abdar, PhD

    Chief Executive Officer

    CEO

    Haston Abdar, PhD

    Chief Executive Officer

    Dr. Abdar earned his PhD in Systems and Control Engineering from Case Western Reserve University, where he co-developed the original Adaptix Neuro concept. He brings over a decade of experience in biomedical systems engineering, electronics design, and embedded software development.

    Previously, he led multidisciplinary R&D teams at CTi Sensors, Inc., overseeing product development from concept through commercialization. A co-inventor on multiple U.S. patents, Dr. Abdar directs BioMotion’s product development, commercialization strategy, and operational execution.
  • Portrait of Angela Ridgel CSO

    Angela Ridgel, PhD

    Chief Scientific Officer

    CSO

    Angela Ridgel, PhD

    Chief Scientific Officer

    Dr. Ridgel is Professor of Exercise Physiology at Kent State University and a nationally recognized expert in exercise-based interventions for Parkinson’s disease. With over 19 years of experience leading clinical studies, she has authored numerous peer-reviewed publications demonstrating the therapeutic benefits of motor-assisted cycling.

    At BioMotion, she oversees clinical study design, outcome validation, and translational research strategy to ensure Adaptix Neuro remains evidence-based and clinically impactful.
  • Portrait of Kenneth A. Loparo CTO

    Kenneth A. Loparo, PhD

    Chief Technology Officer

    CTO

    Kenneth A. Loparo, PhD

    Chief Technology Officer

    Dr. Loparo is an IEEE Life Fellow, AIMBE Fellow, and Arthur L. Parker Professor Emeritus at Case Western Reserve University. With more than 45 years of expertise in nonlinear systems, adaptive control, and stochastic modeling, he is internationally recognized for his contributions to control theory and biomedical engineering.

    He holds numerous U.S. patents and over 400 publications. At BioMotion, he leads adaptive control algorithm development and ensures the technical rigor and scalability of the Adaptix Neuro platform.
  • Portrait of Fred M. Discenzo Advisor

    Fred M. Discenzo, PhD

    Technical Advisor

    Advisor

    Fred M. Discenzo, PhD

    Technical Advisor

    Dr. Discenzo is a retired Rockwell Automation Fellow and former R&D executive with extensive experience translating early-stage technologies into commercially viable products. He holds over 70 U.S. patents and brings deep experience in product strategy, IP development, and commercialization pathways.

    He also serves as Vice President of the Ohio Parkinson Foundation Northeast Region, strengthening BioMotion’s connection to the Parkinson’s community.